Tags Posts tagged with "Medical Marijuana Inc."

Medical Marijuana Inc.

0 1474
marijuana stocks

Medical Marijuana, Inc.’s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children

SAN DIEGO, March 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Mexico garnered national news headlines across Mexico for the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of its RSHO-X™ product in treating children with severe epilepsy. HempMeds® Mexico was the first company to receive government import permits for its cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™) via the Mexican Health Department COFEPRIS.

An article from Mexico newspaper Reforma, “Ayuda cannabidiol a 84% de pacientes,” or “Cannabidiol helps 84% of patients,” explained how 84 percent of children with epilepsy treated with RSHO-X™ halved the number of seizures they suffer from, according to this first clinical study on the use of cannabis in patients with Lennox-Gastaut syndrome in Mexico.

“We are proud that our cannabidiol (CBD) hemp oil product, without THC, has enabled 17% of patients in the study to experience 100 percent relief from their seizures, the best results of any product/medication in the world regarding the reduction of seizures in Lennox-Gastaut patients,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is exciting to see such widespread news coverage of these study results by the Mexico media, as studies that prove the therapeutic benefits of CBD like Dr. Garza’s study will continue to help fuel less restrictive medical cannabis programs not only in Mexico, but across the globe. In addition, as news spreads of this revolutionary treatment for diseases such as epilepsy, more patients and families that suffer from debilitating medical conditions will receive help with medical marijuana.”

The study included 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of 4. Of those 39 patients, who took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced a 50% or greater reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and seven reported a complete elimination of all seizures (17%) over a four-month period, with zero reported side effects.

Results of this study are set to be published in the near future. To view the study, click here.

Other major national Mexico outlets that have reported the results of Dr. Garza’s epilepsy study with RSHO-X™ include:

Contenido

Economiahoy.mx

El Diario.mx

El Imparcial

El Mural

El Universal

Frontera.info

La Cronica

La Jornada

Radio Centro

Yahoo Mexico

Zocalo

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact: Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com

0 1552

Medical Marijuana, Inc.’s HempMeds(R) Signs U.S. Manufacturer Sales Agreement for Over $2,500,000 – Ships First Two Months Supply of 12 Month Contract

SAN DIEGO, Sept. 9, 2015 (GLOBE NEWSWIRE) — HempMeds(R), a Medical Marijuana, Inc. (OTC Pink:MJNA) portfolio company and the Company’s master distributor, is pleased to announce to shareholders and the public that it has signed a U.S. manufacturer for sourcing of its Gold Label cannabidiol (CBD) hemp oil brand Real Scientific Hemp Oil(TM) (RSHO(TM)). The sourcing agreement is for a minimum of $2,500,000 USD for a 12-month period. The first two months of the contract have already been sold, shipped and processed.

The new manufacturer has develop finished natural CBD hemp oil products for both people and pets — and represents an additional new revenue stream for the Company.

“The Company has been working diligently on developing the appropriate sales and distribution strategies,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “This is part of our strategy to scale and grow HempMeds’ sales and bring significant new revenue into the Company. This is the second major contract the company has executed in the past few months, first was the launch of Korea sales channels and this is the second. Our team has been working very hard to secure and develop additional large scale contracted supply agreements in order to diversify our sales channels.”

Hemp is widely regarded as a “whole food” and “super food.” MJNA’s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC.

An industry innovator and pioneer at the global level, HempMeds(R) is the primary sales and marketing arm for Medical Marijuana, Inc. Hemp oil products from HempMeds(R) are readily available to ship to all 50 U.S. states, districts and territories plus more than 40 countries around the world.

For more information on HempMeds and their all-natural hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds(R) through the Company’s social media websites on Facebook and Twitter.

The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s video statement, click here.

About HempMeds

HempMeds(R) offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds(R) is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds(R) is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Contact:
Public Relations contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 858-380-5478
andrew.hard@cmwmedia.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations:
GH Investment Advisors
550 West “C” Street, Ste. 2040
San Diego, CA 92101
Nick Massalas
Office: (858) 264-6500
Toll Free: (877) 964-6463
info@ghinvestmentadvisors.com

0 2796

Medical Marijuana Inc. Announces Second Quarter 2014 Shareholders Report: 20% Growth Quarter-to-Quarter

 

Company Posts Significant Increase in Sales and Mainstream News Media Reports While Relocating Offices and Expanding Operations

SAN DIEGO, Oct. 2, 2014 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA), a leading cannabis and industrial hemp industry innovator, today announced the release of its quarterly financial and shareholders report (Post 09/30/2014 – OTC Markets). The Company had product sales revenues of $4,821,741 compared to $4,017,774 for the prior quarter. Below are the Company’s second quarter 2014 operating and developmental highlights.

HempMeds operating highlights for the second quarter are as follows:

  • HempMeds(TM) posted revenues of $4,091,460 in Q2, an increase from the prior quarter’s revenue
  • Due to popularity and use by its customers, rebranded to simply “HempMeds(TM)” (from HempMedsPX).
  • Countering mainstream media reports that “CBD” is only available in Colorado,HempMeds(TM) launched the “DON’T MOVE” advertising campaign.
  • HempMeds(TM) aligned marketing resources with the Medical Cannabis Network, advertisingCBD-rich hemp oil products to tens of thousands in its online network.
  • HempMeds featured CBD-rich hemp oil products in the “product theater” at The American Academy of Anti-Aging Medicine (A4M) world congress in Orlando, Florida. CBD was a topic that gained attendees continuing education credits during the conference.
  • A third-party laboratory report was published on the quality of CBD-rich hemp oil provided by HempMeds to its customers worldwide.

Media exposure expanded to reach a global audience in the second quarter. Media coverage included:

  • AutismOne’s Voice America Show “A Conversation of Hope” introduced HempMeds as the exclusive gold sponsor of the 2014 global conference.
  • HempMeds was featured by conservative talk show host Roger Hedgecock.
  • Andrew Hard, Director of Public Relations, was featured by Next News Network’s Gary Franchi and explained domestic hemp history and the “green rush” to the network’s 8 million viewers in the Boston and South Florida audiences.
  • During the Chicago Cannabis Conference, HempMeds was featured by global news distribution company AFP reaching millions of viewers worldwide.
  • The Robert Scott Bell Show on Natural News Radio featured executives from HempMeds live, during re-broadcasts in multiple countries and through show downloads on iTunes.
  • HempMeds was featured by Fox5, CBS 8, ABC 13, NBC 3 and the Las Vegas Review Journal during the International Cannabis Association’s business-to-business mentoring conference.
  • Other media highlights included appearances on WGN TV and radio, NBC 5 Chicago and a piece in the Chicago Sun-Times.

Trade shows and expos featuring products from HempMeds(TM) included:

Continuing the Company’s community outreach efforts, the Company supported multiple organizations through sponsorships and charitable donations in the second quarter of 2014. Those organizations included MyCompassion.org, AutismOne, Americans for Safe Access, theNational Cannabis Industry Association, and International Cannabis Association.

Wellness Managed Services

Medical Marijuana Inc.‘s subsidiary Wellness Managed Services launched a joint venture with MPS Security under the brand MPS International (MPSI). Operational highlights from Q2 include the following:

In addition to these highlights, MPSI expanded their service offerings to include security consultative services.

CanChew Biotechnologies

CanChew(TM) Biotechnologies expanding their marketing efforts in the second quarter. Highlights include:

  • Sales of CanChew(TM) gum were $12,697 in Q2
  • Relocated east coast office to the “Trillion Dollar Mile” in Englewood Cliffs, New Jersey
  • Legal staff secured multiple trademarks
  • Augmented staff in the areas of: marketing, online and social media, public relations and web development
  • CanChew(TM) Biotechnologies website was redesigned
  • Executive interviews were conducted for publications
  • Published features include:
    • Readers Digest Magazine
    • Newsweek Magazine
    • Dr. Oz The Good Life Magazine

The Company is currently seeking to expand its direct sales force. Those interested in a career development with an innovative phytoceutical global manufacturer, please send resumes toCanChew(TM) Biotechnologies 560 Sylvan Avenue, 3rd Floor Englewood Cliffs, NJ 07632 (855) 232-9953 or by email to info@canchewbiotech.com

HempWire, LLC

aNew Chocolate, LLC

Red Dice Holdings

  • Medical Marijuana Inc. and Dixie Holdings (DH), the owner of Dixie Elixirs and Edibles, one of America’s first revolutionaries in cannabis-infused edibles, topicals and tinctures, agreed to execute a mutually beneficial Asset Purchase and Settlement Agreement. As part of the agreement, Dixie Holdings agreed to purchase its brand and all IP from Red Dice Holdings pertaining to Dixie Elixirs and Edibles, enabling DH to develop and expand its family of THC-infused products; also MJNA will own the brand and IP specific to Dixie Botanicals, allowing it to focus that brand specifically on Hemp-derived CBD-based products.
  • Medical Marijuana, Inc. and Dixie Elixirs agree to an amicable resolution of Red Dice Holdings partnership.
  • Revenue of $352,911.71 in Q2

A statement from MJNA.

Medical Marijuana Inc. is extremely pleased to announce a Q2 performance that shows significant revenue growth. This took place while the Company moved headquarters and expanded operations. The Company is extremely proud of the success of all of our portfolio companies and we remain grateful to our loyal customers and staff who made this possible.

One of the MJNA portfolio companies that is blazing a trail is HempMeds(TM). The Company’s mission is to be the most trusted supplier of CBD-rich hemp oil products. As HempMeds(TM) continued to grow its strategic partnerships and marketing endeavors, the news media took notice of the open availability of CBD-rich hemp oil products from HempMeds(TM). The increased awareness of CBD-rich hemp oil products was a catalyst to achieving growth quarter-to-quarter. As a result, HempMeds(TM) has proven to, once again, be a growth engine for the MJNA family of companies.

The Company is staffed with an extremely talented group of individuals who believe in giving back through community outreach. MJNA‘s support was shared with a wide range of non-profit organizations that helped increase awareness of CBD-rich hemp oil products to their members, sponsors and supporters. The collective efforts of these organizations created a platform for thousands of consumers to learn about CBD-rich hemp oil products and their open availability.MJNA is honored to contribute to these wonderful organizations and be of continued service.

As the Company continues to grow, the MJNA portfolio of companies seeks qualified and driven individuals. Those interested in being a part of a rapidly emerging industry through established companies please submit a resume to HR@hempmedspx.com.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

About HempMeds

HempMeds(TM) offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds(TM) is a corporate portfolio company of Medical Marijuana, Inc.(OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds(TM) is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About LiveWire, LLC

LiveWire Ergogenics Inc. (LVVV) was formed in 2008 and its products are available for purchase at thousands of retail outlets nationwide, or are available online at:http://www.livewireenergy.com.

About CanChew Biotechnologies

CanChew Biotechnologies focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products as well as food and nutraceutical products for general well-being.

The company is focused on the R&D and execution of their clinical development plan and potential out-licensing of their technology. Clinical development focuses on the R&D of the formulation, production and the development of chewing gum-based products for the treatment of conditions like pain, nausea and vomiting, anorexia, spasticity and various other medical issues. For more information on the company, visit CanChewBiotech.com.

About Wellness Managed Services

Wellness Managed Services provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics throughout North America. The services offered range from practice management to product distribution. Our mission is to provide a comprehensive array of clinically supporting health and wellness products and services which will attract patients while providing for a fully operational, profitable enterprise. We seek to provide facilities and patients alike with the latest in quality products and support services that will serve the health and wellness community. For more info, click here.

About MPSI:

MPS International (MPSI) is a consulting firm that provides security consultative services to business and individuals in the legal cannabis industry. When security officers are needed, MPSI contracts exclusively with MPS Security to provide uniformed security management and officers.

MPSI was created as a specialized division of MPS Security. With over 46 years of experience providing professional security services, MPS Security is uniquely qualified to bring high quality security management and security solutions to the new and growing cannabis industry. Our professional experience and qualifications are helping to legitimize the expanding cannabis industry by reducing crime and assisting legal businesses and individuals to operate in accordance with all federal, state and local laws and regulations. For more details visitwww.Security-MPSI.com, email security@security-mpsi.com or call (866) 678-4408.

About Red Dice Holdings

Red Dice Holdings, LLC (“Red Dice”) is the owner of the brand Dixie Botanicals. The company has one of the most recognizable cannabis and hemp brands in the world. For more information on Red Dice Holdings, click here.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
Director of PR, HempMeds
P. 858-380-5478
andrew.hard@hempmeds.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements